Kennedy antidepressant prescribing guidance debate
Analysis based on 10 articles · First reported Sep 10, 2026 · Last updated Sep 11, 2026
The debate over antidepressant prescribing could weigh on demand expectations for antidepressant manufacturers if the Health and Human Services guidance leads to reduced prescriptions, though no formal policy change has been enacted. For now, the impact is limited to sentiment around pharmaceutical companies with significant antidepressant portfolios, with little immediate effect on broader markets.
In May 2026, United States — United States Department of Health and Human Services Secretary Robert F. Kennedy Jr. launched an effort encouraging doctors to find alternatives to antidepressants and other psychiatric drugs when treating depression. The initiative is discussed in opinion articles written by Andrew McLean, a psychiatrist and clinical professor at University of North Dakota, republished by The Conversation US. McLean acknowledges that antidepressants, particularly selective serotonin reuptake inhibitors such as fluoxetine (Prozac), are likely overused in mild cases, but argues the picture is more nuanced: the drugs are effective for moderate to severe depression, and expanded telehealth access since the COVID-19 pandemic has enabled many Americans to receive needed treatment. He notes that most antidepressant prescriptions in the United States are written by primary care providers rather than psychiatrists, and that systemic issues in the healthcare system, including limited access to talk therapy and specialized care, drive prescribing patterns. Kennedy has claimed that stopping antidepressants can be harder than quitting heroin, a claim McLean says is rare though not unheard of; research indicates about a quarter of patients experience withdrawal symptoms, with 3% severe. The articles are opinion pieces and do not announce new regulatory action beyond the May 2026 effort.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard